Global Veterinary Stereotactic Radiosurgery System Market, By Product (Microsurgical Instrumentation, Optical/Viewing Instruments and Others), Modality Type (Gamma Knife, Linear Accelerator, Particle Beam Radiation therapy, Cyber Knife) - Industry Trends and Forecast to 2029.
Veterinary Stereotactic Radiosurgery System Market Analysis and Size
Stereotactic radiation therapy (SRT) is a method used to deliver a curative dose of external beam radiation therapy. With rapid dose drop-off and precision radiation targeting, this treatment enables for very high doses of radiation to be given without increasing the toxicity to adjacent normal tissues. By altering DNA, this treatment destroys cancer cells or slows their proliferation. The market is expected to be further fueled by elements including government initiatives, rising investments in the veterinary healthcare sector, and quickening technology breakthroughs in noninvasive SRS systems.
Data Bridge Market Research analyses that the veterinary stereotactic radiosurgery system market which was USD 439.94 million in 2021, would rocket up to USD 662.48 million by 2029, and is expected to undergo a CAGR of 5.25% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Veterinary Stereotactic Radiosurgery System Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Microsurgical Instrumentation, Optical/Viewing Instruments and Others), Modality Type (Gamma Knife, Linear Accelerator, Particle Beam Radiation therapy, Cyber Knife)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
PetCure Oncology (U.S.), Varian Medical Systems, Inc. (U.S.), Accuray Incorporated (U.S.), BD (U.S.), C. R. Bard, Inc. (U.S.), Eckert & Ziegler (Germany), Elekta (Sweden), Hitachi, Ltd. (Japan), IntraOp Medical, Inc. (U.S.), Ion Beam Applications SA (Belgium), Isoray, Inc. (U.S.), Mevion Medical Systems (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Veterinary stereotactic radiosurgery (SRS) treats cancers and other health issues in the neck, lungs, brain, liver, spine, and other areas of the body by using a number of finely focused radiation beams. During the procedure, no incisions are made. Instead, stereotactic radiosurgery makes use of 3D imaging to concentrate high radiation doses on the afflicted spot while minimising damage to the healthy tissue around it.
Veterinary Stereotactic Radiosurgery System Market Dynamics
Drivers
- Rise in pet population
The primary factor promoting business growth is the expanding use of stereotactic radiosurgery system (SRS) for the treatment of cancer in pets along with an increase in the pet population. The market is expanding thanks to the widely favourable adoption of frameless stereotactic radiosurgery for the treatment of cerebral tumefaction in dogs with favourable clinical outcomes.
- Rise in animal healthcare industry
Other factors that are presumed to aid the syndicate include administrative measures, rising costs in the animal healthcare industry, and accelerated technical advancements in non-invasive SRS orderliness.
Opportunities
- Increase in the number of research and development activities
The primary factor driving growth for the worldwide veterinary stereotactic radiosurgery system market is the increasing need for stereotactic radiosurgery to treat dogs with cancer.
The growing number of pets afflicted by various cancers in both established and developing nations could be another element in the future that generates profitable revenue-generating prospects for market participants.
Restraints/Challenges
On the other hand, the high cost associated with surgeries will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
This veterinary stereotactic radiosurgery system market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary stereotactic radiosurgery system market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Veterinary Stereotactic Radiosurgery System Market
The COVID-19 epidemic had a detrimental effect on the expansion of the market for veterinary stereotactic radiosurgery systems worldwide. Governments implemented harsh social segregation laws and lockdowns in an effort to stop the virus's spread as instances grew throughout the world. This resulted in a decrease in the number of radiation therapies performed by veterinary hospitals and clinics and had an effect on the demand for stereotactic radiosurgery systems in those institutions.
Recent Development
- In March 2020, Stereotactic radiosurgery (SRS) and its associated applications will be the focus of web-based instructional presentations offered by ZAP Surgical Systems, Inc. The Radiosurgery Society, AANS, and other scientific conferences have recently been postponed due to the COVID-19 situation, and this has led to a need for "social distancing," so the entire programme will be presented via webinar at no cost.
- In February 2019, A facility addition to the Hixson-Lied Small Animal Hospital at the College of Veterinary Medicine that can offer radiation therapy for animals with cancer opened its doors. After staff training and the commissioning of the linear accelerator, a 6-year-old unit that was originally utilised in a hospital for people and then restored for Iowa State, construction was completed in late August.
Global Veterinary Stereotactic Radiosurgery System Market Scope
The veterinary stereotactic radiosurgery system market is segmented on the basis of product and modality type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Microsurgical Instrumentation
- Optical/Viewing Instruments
- Others
Modality Type
- Gamma Knife
- Linear Accelerator
- Particle Beam Radiation therapy
- Cyber Knife
Veterinary Stereotactic Radiosurgery System Market Regional Analysis/Insights
The veterinary stereotactic radiosurgery system market is analysed and market size insights and trends are provided by country, product and modality type as referenced above.
The countries covered in the veterinary stereotactic radiosurgery system market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the veterinary stereotactic radiosurgery system market due to the high prevalence of pets surfing from cancer, mounting pet population, and concern of pet owners is driving the market growth in the pockets of North America.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 because of growing willingness to take improved care of pets among families residing in countries such as India and China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Veterinary Stereotactic Radiosurgery System Market Share Analysis
The veterinary stereotactic radiosurgery system market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veterinary stereotactic radiosurgery system market.
Some of the major players operating in the veterinary stereotactic radiosurgery system market are:
- PetCure Oncology (U.S.)
- Varian Medical Systems, Inc. (U.S.)
- Accuray Incorporated (U.S.)
- BD (U.S.)
- C. R. Bard, Inc. (U.S.)
- Eckert & Ziegler (Germany)
- Elekta (Sweden)
- Hitachi, Ltd. (Japan)
- IntraOp Medical, Inc. (U.S.)
- Ion Beam Applications SA (Belgium)
- Isoray, Inc. (U.S.)
- Mevion Medical Systems (U.S.)
SKU-